Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2025-12-26 @ 10:44 PM
NCT ID:
NCT00472212
Eligibility Criteria:
Inclusion Criteria:
* Age 6-11 years;
* At least +1.00D Hyperopia (farsightedness);
* \< +4.00D Hyperopia;
* \< 1.00D Astigmatism;
* \< 1.00D Anisometropia (difference between the two eyes);
* Willing to be randomized;
* Best corrected visual acuity of 20/25 or better in each eye;
* Willing to wear eyeglasses full-time;
* Willing to return for follow-up visits
Exclusion Criteria:
* Previous wear of glasses or contacts for farsightedness/hyperopia;
* Eye disease that affects visual function;
* Amblyopia (lazy eye);
* Strabismus (eye turn);
* History of strabismus surgery;
* Chronic use of any of the following medications:
* Antianxiety agents (Librium, Valium)
* Antiarrythmic agents (Cifenline, Cibenzoline)
* Anticholinergics (Motion sickness patch - scopolamine)
* Bladder spasmolytic (Propiverine)
* Chloroquine
* Phenothiazines (Compazine, Mellaril, Thorazine)
* Tricyclic antidepressants (Elavil, Nortriptyline, Tofranil)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
11 Years
Study:
NCT00472212
Study Brief:
Protocol Section:
NCT00472212